Cancer Advances
  • Home
  • About
  • Our Science
    • Recent Publications
    • Our Target
    • Our Product
  • News & Events
  • Contact
Select Page
https://www.canceradvances.com/wp-content/uploads/2021/08/AACR21_Smith-JP-presentation-1.mp4

Vaccination with Polyclonal Antibody Stimulator PAS Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model

Aug 18, 2021 | media-presentation

  About Cancer Advances, Inc. Cancer Advances Inc. (Durham, NC) is a biotechnology company focused on impacting human health and preventing the progression of gastrointestinal cancers by enhancing the adaptive immune system.  The company is led by an experienced...

Recent Posts

  • Cancer Advances, Inc. Announces Issuance of New U.S. Patent
  • Cancer Advances, Inc. Announces Abstract and Poster Presentation at ASCO GI – Role of an anti-gastrin vaccine (PAS) in combination with a PD-1 antibody on growth and metastasis of gastric cancer
  • Cancer Advances, Inc. Announces Publication, “Gastrin Vaccine Alone and in Combination with an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer” in Frontiers in Oncology
  • Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model
  • Vaccination with Polyclonal Antibody Stimulator PAS Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model

Recent Comments

    © 2020 Cancer Advances, Inc. All rights reserved.